NCT00114803View on ClinicalTrials.gov

Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

October 31, 2006

Conditions

Ulcerative ColitisCrohn's Disease

Interventions

DRUG

Calcitonin nasal spray (salmon)

Trial Locations (1)

02115

Children's Hospital Boston, Boston

All Listed Sponsors

collaborator

Crohn's and Colitis Foundation

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Boston Children's Hospital

OTHER

NCT00114803 - Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter